JAKKS PACIFIC INC financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data JAKKS PACIFIC INC files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	707	613	568	599	516	621	796	712	691	571
Cost of revenue	484	457	412	439	366	438	585	488	478	386
Gross profit	223	156	156	159	150	183	211	223	213	185
Research and development							9.79	9.3	10.9	10.8
Selling, general and administrative	206	205	185	99.6	135	144	150	164	173	171
General and administrative					90.4	98.7	115	127	133	133
Operating income	17.1	-64.2	-32.2	-17.8	12.9	38.8	61	59.1	39.7	14.2
Interest expense	13	9.83	10.2	15.9	21.6	14.1	11.2	6.45	1.1	0.47
Interest income	0.05	0.04	0.07	0.09	0.02	0.01	0.13	1.34	0.84	1
Other non-operating income	0.31	0.34	0.15	-1.16	0.3	0.45	0.8	0.56	0.3	0.45
Pre-tax income	5.38	-81.4	-39.5	-53.5	-13.4	-5.66	50.1	44.9	39.7	14.8
Income tax	4.13	1.61	2.95	1.91	0.74	0.23	-41	6.83	5.53	4.89
Net income to minority interests	0.01	0.06	-0.06	0.17	0.13	0.12	-0.33	-0.29	0.28	0
Net income	1.24	-83.1	-42.4	-55.5	-14.3	-6.01	91.4	38.4	33.9	9.87
EBITDA	40.1	-43.2	-15.1	-0.16	23.8	49	71.5	67.7	49.7	24.5
EPS, basic	0.08	-3.89	-1.83	-21.57	-4.27	-0.98	9.33	3.70	3.27	0.88
EPS, diluted	0.07	-3.89	-1.83	-21.57	-4.27	-0.98	8.86	3.48	3.14	0.86
Shares, basic (weighted)	16.5	21.3	23.1	2.6	3.63	7.5	9.65	9.96	10.8	11.2
Shares, diluted (weighted)	16.7	21.3	23.1	2.6	3.63	7.5	10.2	10.6	11.2	11.5
Dividend per share										0.25

Balance sheet

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash and equivalents	86.1	65	53.3	61.6	88	44.5	85.3	72.4	69.9	52.2
Receivables	174	142	122	118	102	147	103	124	132	138
Inventory	75.4	58.4	53.9	54.3	38.6	84	80.6	52.6	52.8	59.8
Other current assets	17.1	16.8	15.8	0	0	0.19	0.12	0.24	0.13	0.4
Total current assets	353	283	250	260	251	288	275	255	269	269
Property, plant and equipment	22.8	23.2	20.9	15.3	13.5	13.1	14.9	14.6	15.6	19
Lease right-of-use assets				32.1	24.4	17	19.9	23.6	53.3	46.8
Goodwill	43.2	35.4	35.1	35.1	35.1	35.1	35.1	35.1	35.1	35.1
Intangible assets	33.1	22.2	17.3	3.19	2.03	1.02	0
Other non-current assets	2.16	6.58	19.1	18.9	3.22	2.99	2.47	2.16	1.78	2.68
Total assets	464	370	343	365	329	357	405	399	445	442
Accounts payable	51.7	49.9	57.6	61.2	30.3	50.2	33.7	42.2	42.6	55.6
Accrued liabilities	38.6	42.1	29.9	39.5	39.3	47.1	38	45.1	48.5	43.1
Deferred revenue	0.78	3.92	0.56	0.56	0.94	2.51	0.92	0.7	0.25
Short-term debt	10	21.2	27.2	1.91	5.95	2.1	25.5	0
Total current liabilities	117	136	144	153	138	173	178	149	149	148
Long-term debt	203	133	140	175	150	93.4	41.6	0
Lease liabilities				25.6	16.9	8.04	9.86	16.7	48.4	39.6
Other non-current liabilities	5	4.54	4.41	5.41	8.06			2.7
Total liabilities	329	276	291	361	315	296	254	203	204	193
Total debt		21.2	140	52.7	34.1	98.5	68.9
Paid-in capital	178	216	218	201	222	273	275	279	297	302
Retained earnings	-2.15	-85.2	-128	-183	-197	-203	-112	-73.6	-39.7	-41
Treasury stock	-24	-24	-24	0
Other comprehensive income	-17.2	-13.1	-15.8	-14.4	-12.4	-13	-17.5	-15.6	-17.2	-12.3
Shareholders' equity	134	93.5	50.7	2.94	11.7	56.6	146	189	240	249
Minority interests	0.91	0.97	0.91	1.08	1.21	1.33	1	0.71	0.5	0
Total equity	135	94.5	51.6	4.02	12.9	57.9	147	190	241	249
Total liabilities and equity	464	370	343	365	329	357	405	399	445	442
Shares outstanding	19.4	27	29.2	3.52	5.69	9.52	9.74	10.1	11	11.3

Cash flow statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Net income	1.25	-83	-42.4	-55.4	-14.1	-5.89	91.1	38.1	34.2	9.87
Depreciation and amortization	22.9	21	17.1	17.6	10.9	10.3	10.6	8.59	10	10.2
Stock-based compensation	1.62	3.11	2.43	2.87	2.3	2.09	5.08	8.03	9.54	10.9
Deferred income tax	-0.26	-1.25	0.21	-0.98	0.11	-0.07	-57.9	-10.3	-2.25	0.83
Change in receivables	-10.2	19.3	10.6	3.47	14.1	-43.7	44.4	-21.8	-9.23	-7.03
Change in inventory	-14.9	17	4.55	-0.38	15.6	-45.3	3.34	28	-0.13	-7.03
Change in payables	10.6	-0.38	9.52	4.87	-12.8	19.8	-18.1	9.6
Cash from operations	16.7	11.4	-0.62	21.8	43.6	-5.88	86.1	66.4	38.9	8.49
Capital expenditures	-14.8	-14.9	-11.8	-9.42	-8.27	-8.22	-10.4	-8.91	-11.2	-9.56
Cash from investing	-15.1	-14.8	-11.6	-9.4	-8.19	-8.19	-10.4	-8.91	-12.9	-12.3
Debt issued	0	0	0	27.4	0	96.3	0	0
Debt repaid			0	-20	-15.1	-126	0	0
Stock issued	0	19.3	0	0
Share buybacks	-13.5	0	0
Dividends paid								0	0	-11.2
Cash from financing	-12	-21.4	7.98	-5.77	-10.9	-32.8	-31	-72.3	-26.9	-17.1
Exchange rate effect	-6.17	3.68	-2.49	1.43	1.98	-0.51	-4.53	1.86	-1.56	4.89
Net change in cash	-10.3	-24.8	-4.29	6.66	24.4	-46.9	44.7	-14.8	-0.86	-21
Free cash flow	1.96	-3.53	-12.4	12.4	35.3	-14.1	75.7	57.5	27.7	-1.07
Interest paid	9.86	8.78	9.45	6.43	13.2	13.4	9.04	4.72	0.47	0.37
Income taxes paid	2.17	4.08	2.1	0.03	3.85	1.62	7.67	21.6	16.4	5.01

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to September 30, 2026; growth uses fiscal years. Valuation uses the share price of $36.39 on November 10, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	32.1%	Gross profit / revenue.
Operating margin	3.7%	Operating income / revenue.
EBITDA margin	4.4%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	5.0%	Pre-tax income / revenue.
Net margin	4.2%	Net income / revenue.
FCF margin	5.7%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	8.1%	Cash from operations / revenue.
Effective tax rate	17.1%	Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)	9.4%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	4.9%	Net income / average total assets.
Return on invested capital (ROIC)	8.2%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
SG&A / revenue	28.4%	Selling, general and administrative expense / revenue.
Stock-based pay / revenue	1.9%	Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue	2.4%	Capital expenditures / revenue.
D&A / revenue	0.7%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	-17.4%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	-10.5%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	2.0%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	-13.1%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	-4.3%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	4.3%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y	-64.2%	Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y	-38.4%	Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 5y	2.0%	Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y	-50.8%	EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y	-30.1%	Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y	0.5%	Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y	-70.9%	Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y	-52.4%	Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS growth, 1y	-72.6%	EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y	-54.0%	Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow growth, 1y	-78.2%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y	-53.8%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y	-27.9%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y	-103.9%	Free cash flow vs the same period a year earlier. Only from a positive base.
Book value growth, 1y	3.6%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	19.6%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	84.3%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	-0.6%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	2.9%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	6.1%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	2.4%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	4.2%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	25.9%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	1.67x	Current assets / current liabilities.
Quick ratio	1.31x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.20x	(Cash + short-term investments) / current liabilities.
Liabilities / assets	47.6%	Total liabilities / total assets.
Interest coverage	94.5x	Operating income / interest expense.
Working capital	$146.0M	Current assets - current liabilities.
Goodwill and intangibles / assets	6.6%	(Goodwill + intangible assets) / total assets.
Tangible book value	$242.4M	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	1.19x	Revenue / average total assets.
Fixed asset turnover	28.4x	Revenue / average property, plant and equipment.
Inventory turnover	6.68x	Cost of revenue / average inventory.
Days inventory	55 days	365 x average inventory / cost of revenue.
Receivables turnover	2.61x	Revenue / average receivables.
Days sales outstanding	140 days	365 x average receivables / revenue.
Days payables	83 days	365 x average accounts payable / cost of revenue.
Cash conversion cycle	112 days	Days inventory + days sales outstanding - days payables.
FCF conversion	136.6%	Free cash flow / net income, when net income is positive.
Capex / operating cash flow	29.5%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	$2,171.00	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$52,050.00	Revenue / diluted weighted shares.
FCF per share	$2,965.00	Free cash flow / diluted weighted shares.
Operating cash flow per share	$4,205.00	Cash from operations / diluted weighted shares.
Book value per share	$24.18	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	$21.13	Tangible book value / shares outstanding.
Cash per share	$3.84	(Cash + short-term investments) / shares outstanding.
Payout ratio	43.6%	Dividends paid / net income, when net income is positive.
Dividends / FCF	31.9%	Dividends paid / free cash flow, when free cash flow is positive.

Valuation

Metric	Value	How it is calculated
Market cap	$416.5M	Share price x shares outstanding.
Enterprise value	$372.5M	Market cap + total debt - cash - short-term investments.
P/E	15.9x	Market cap / net income. Only when net income is positive.
P/S	0.66x	Market cap / revenue.
P/B	1.50x	Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book	1.72x	Market cap / tangible book value, when positive.
P/FCF	11.7x	Market cap / free cash flow. Only when free cash flow is positive.
P/OCF	8.22x	Market cap / cash from operations, when positive.
EV/Sales	0.59x	Enterprise value / revenue.
EV/EBIT	16.2x	Enterprise value / operating income, when both are positive.
EV/EBITDA	13.5x	Enterprise value / EBITDA, when both are positive.
EV/FCF	10.4x	Enterprise value / free cash flow, when both are positive.
FCF yield	8.6%	Free cash flow / market cap.
Earnings yield	6.3%	Net income / market cap (the inverse of P/E).
Dividend yield	2.7%	Dividends paid over the period / market cap.
Shareholder yield	2.7%	(Dividends paid + share buybacks) / market cap.

What was JAKKS PACIFIC INC's revenue in fiscal 2025?

JAKKS PACIFIC INC reported revenue of $570.7M for fiscal 2025, 17.4% lower than the year before.

Was JAKKS PACIFIC INC profitable in fiscal 2025?

Yes. Net income was $9.9M, a net margin of 1.7%.

How much free cash flow did JAKKS PACIFIC INC generate in fiscal 2025?

Cash from operations of $8.5M minus capital expenditures of $9.6M left free cash flow of -$1.1M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to JAKKS PACIFIC INC